AAAAAA
Results: 1-25/31
Authors:
WEBB A
ALMOUNDHRI M
SOUBERBIELLE BE
NORTON A
PRIEST K
RYAN C
MENDES R
ASHLEY S
SMITH IE
OBRIEN MER
Citation: A. Webb et al., A RANDOMIZED STUDY OF SRL172 (MYCOBACTERIUM VACCAE) IN PATIENTS WITH ADVANCED LUNG-CANCER TREATED WITH CHEMOTHERAPY, Annals of oncology, 9, 1998, pp. 421-421
Authors:
MIDDLETON GW
SMITH IE
OBRIEN MER
NORTON A
HICKISH T
PRIEST K
SPENCER L
ASHLEY S
Citation: Gw. Middleton et al., GOOD SYMPTOM RELIEF WITH PALLIATIVE MVP (MITOMYCIN-C, VINBLASTINE ANDCISPLATIN) CHEMOTHERAPY IN MALIGNANT MESOTHELIOMA, Annals of oncology, 9(3), 1998, pp. 269-273
Authors:
WEBB A
OBRIEN MER
Citation: A. Webb et Mer. Obrien, WHERE TO GO WITH NEW EXPENSIVE TREATMENTS IN NSCLC, British Journal of Cancer, 78(2), 1998, pp. 159-162
Authors:
DEBOER RH
GOLDSTRAW P
PASTORINO U
OBRIEN MER
RAMAGE F
ASHLEY S
SMITH IE
Citation: Rh. Deboer et al., PREOPERATIVE CHEMOTHERAPY IN EARLY-STAGE RESECTABLE NON-SMALL-CELL LUNG-CANCER - A RANDOMIZED FEASIBILITY STUDY JUSTIFYING A MULTICENTER PHASE-III TRIAL, British Journal of Cancer, 78, 1998, pp. 4-4
Authors:
WEBB A
ALMOUNDHRI M
SOUBERBIELLE BE
NORTON A
PRIEST K
RYAN C
MENDES R
ASHLEY S
SMITH IE
OBRIEN MER
Citation: A. Webb et al., A RANDOMIZED STUDY OF SRL172 (MYCOBACTERIUM-VACCAE) IN PATIENTS WITH ADVANCED LUNG-CANCER TREATED WITH CHEMOTHERAPY, British Journal of Cancer, 78, 1998, pp. 5-5
Authors:
HICKISH TF
SMITH IE
OBRIEN MER
ASHLEY S
MIDDLETON G
Citation: Tf. Hickish et al., CLINICAL BENEFIT FROM PALLIATIVE CHEMOTHERAPY IN NONSMALL CELL LUNG-CANCER EXTENDS TO THE ELDERLY AND THOSE WITH POOR PROGNOSTIC FACTORS, British Journal of Cancer, 78(1), 1998, pp. 28-33
Authors:
RUBIO C
HILL ME
MILAN S
OBRIEN MER
CUNNINGHAM D
Citation: C. Rubio et al., IDIOPATHIC PNEUMONIA SYNDROME AFTER HIGH-DOSE CHEMOTHERAPY FOR RELAPSED HODGKINS-DISEASE, British Journal of Cancer, 75(7), 1997, pp. 1044-1048
Authors:
OBRIEN MER
SMITH IE
Citation: Mer. Obrien et Ie. Smith, THE PROGNOSTIC IMPLICATIONS OF CHEMOTHERAPY IN THE TREATMENT OF BREAST-CANCER, Current opinion in obstetrics & gynecology, 8(1), 1996, pp. 21-26
Authors:
OBRIEN MER
MONTES A
POWLES TJ
Citation: Mer. Obrien et al., REPLACEMENT THERAPY AS TREATMENT OF BREAST-CANCER - A PHASE-II STUDY OF ORG OD-14 (TIBILONE), British Journal of Cancer, 73(9), 1996, pp. 1086-1088
Authors:
BONNEFOI H
SMITH IE
OBRIEN MER
SEYMOUR MT
POWLES TJ
ALLUM WH
EBBS S
BAUM M
Citation: H. Bonnefoi et al., PHASE-II STUDY OF CONTINUOUS INFUSIONAL 5-FLUOROURACIL WITH EPIRUBICIN AND CARBOPLATIN (INSTEAD OF CISPLATIN) IN PATIENTS WITH METASTATIC LOCALLY ADVANCED BREAST-CANCER (INFUSIONAL ECARBOF) - A VERY ACTIVE ANDWELL-TOLERATED OUTPATIENT REGIMEN, British Journal of Cancer, 73(3), 1996, pp. 391-396
Authors:
OBRIEN MER
MILAN S
CUNNINGHAM D
JONES AL
NICOLSON M
SELBY P
HICKISH T
HILL M
GORE ME
VINER C
Citation: Mer. Obrien et al., HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANT IN RELAPSED HODGKINS-DISEASE - A PRAGMATIC PROGNOSTIC INDEX, British Journal of Cancer, 73(10), 1996, pp. 1272-1277
Authors:
OBRIEN MER
BONNEFOI H
SEYMOUR M
WALSH G
RAMAGE F
SMITH IE
Citation: Mer. Obrien et al., INFUSIONAL 5-FLUOROURACIL (F) WITH EPIRUBICIN (E) AND CARBOPLATIN (ECARBOF) IN ADVANCED METASTATIC BREAST-CANCER (ABC) - CAN CARBO REPLACE CISPLATIN (C), European journal of cancer, 31A, 1995, pp. 367-367
Authors:
ELLIS PA
NORMAN A
HILL A
OBRIEN MER
NICHOLSON M
HICKISH T
CUNNINGHAM D
Citation: Pa. Ellis et al., EPIRUBICIN, CISPLATIN AND INFUSIONAL 5-FLUOROURACIL (5-FU) (ECF) IN HEPATOBILIARY TUMORS, European journal of cancer, 31A(10), 1995, pp. 1594-1598
Authors:
ANDERSON JR
ARMITAGE JO
VOSE JM
BIERMAN P
WEISENBURGER D
CUNNINGHAM D
OBRIEN MER
MIDDLETON G
WEBB A
MEAD GM
WHITEHOUSE JMA
PROCTOR SJ
Citation: Jr. Anderson et al., CHLVPP THERAPY FOR HODGKINS-DISEASE - EXPERIENCE OF 960 PATIENTS, Annals of oncology, 6(2), 1995, pp. 167-172
Authors:
POWLES TJ
HICKISH TF
MAKRIS A
ASHLEY SE
OBRIEN MER
TIDY VA
CASEY S
NASH AG
SACKS N
COSGROVE D
MACVICAR D
FERNANDO I
FORD HT
Citation: Tj. Powles et al., RANDOMIZED TRIAL OF CHEMOENDOCRINE THERAPY STARTED BEFORE OR AFTER SURGERY FOR TREATMENT OF PRIMARY BREAST-CANCER, Journal of clinical oncology, 13(3), 1995, pp. 547-552
Authors:
OBRIEN MER
MATUTES E
CUNNINGHAM D
HILL M
EMMETT E
ELLIS PA
MILAN S
HICKISH T
MERCIECA J
CATOVSKY D
Citation: Mer. Obrien et al., FLUDARABINE IN LYMPHOPROLIFERATIVE DISORDERS - THE ROYAL-MARSDEN-HOSPITAL EXPERIENCE, Leukemia & lymphoma, 14, 1994, pp. 17-23
Authors:
OBRIEN MER
CASEY S
TRELEAVEN J
POWLES TJ
Citation: Mer. Obrien et al., USE OF ERYTHROPOIETIN IN THE MANAGEMENT OF THE HEMOLYTIC-UREMIC SYNDROME INDUCED BY MITOMYCIN-C TAMOXIFEN, European journal of cancer, 30A(6), 1994, pp. 894-895
Authors:
OBRIEN MER
DOWSETT M
FRYATT I
WILTSHAW E
Citation: Mer. Obrien et al., STEROID-HORMONE PROFILE IN POSTMENOPAUSAL WOMEN WITH OVARIAN-CANCER, European journal of cancer, 30A(4), 1994, pp. 442-445
Authors:
OBRIEN MER
PERREN T
TAN S
FISHER C
WILTSHAW E
Citation: Mer. Obrien et al., THE ENDODERMAL SINUS TUMOR AND CLEAR-CELL OVARIAN-CANCER, Annals of oncology, 5(8), 1994, pp. 753-756
Authors:
JONES AL
SMITH IE
OBRIEN MER
TALBOT D
WALSH G
RAMAGE F
ROBERTSHAW H
ASHLEY S
Citation: Al. Jones et al., PHASE-II STUDY OF CONTINUOUS-INFUSION FLUOROURACIL WITH EPIRUBICIN AND CISPLATIN IN PATIENTS WITH METASTATIC AND LOCALLY ADVANCED BREAST-CANCER - AN ACTIVE NEW REGIMENT, Journal of clinical oncology, 12(6), 1994, pp. 1259-1265
Authors:
POWLES TJ
JONES AL
ASHLEY SE
OBRIEN MER
TIDY VA
TRELEAVAN J
COSGROVE D
NASH AG
SACKS N
BAUM M
MCKINNA JA
DAVEY JB
Citation: Tj. Powles et al., THE ROYAL-MARSDEN-HOSPITAL PILOT TAMOXIFEN CHEMOPREVENTION TRIAL, Breast cancer research and treatment, 31(1), 1994, pp. 73-82
Authors:
SOUBERBIELLE BE
OBRIEN MER
Citation: Be. Souberbielle et Mer. Obrien, USE OF WHO PARTOGRAM IN DEVELOPING-COUNTRIES, Lancet, 344(8916), 1994, pp. 193-193
AGGRESSIVE MANAGEMENT OF DOXORUBICIN-INDUCED CARDIOMYOPATHY ASSOCIATED WITH LOW-DOSES OF DOXORUBICIN
Authors:
SRISKANDAN S
OBRIEN MER
SMITH IE
COLLINS P
GORE ME
Citation: S. Sriskandan et al., AGGRESSIVE MANAGEMENT OF DOXORUBICIN-INDUCED CARDIOMYOPATHY ASSOCIATED WITH LOW-DOSES OF DOXORUBICIN, Postgraduate medical journal, 70(828), 1994, pp. 759-761
Authors:
OBRIEN MER
NICOLSON M
MONTES A
TIDY A
ASHLEY S
POWLES TJ
Citation: Mer. Obrien et al., PHASE-I STUDY OF MITOXANTRONE, METHOTREXATE AND MITOMYCIN WITH GRANULOCYTE-COLONY-STIMULATING FACTOR (FILGRASTIM) IN PATIENTS WITH ADVANCEDBREAST-CANCER, British Journal of Cancer, 70(5), 1994, pp. 980-983
Authors:
CUNNINGHAM D
HILL ME
MILAN S
MANSI JL
SMITH IE
CATOVSKY D
GORE M
OBRIEN MER
NICOLSON M
HICKISH T
Citation: D. Cunningham et al., VEEP CHEMOTHERAPY FOR ADULT HODGKINS-DISEASE - ASSESSMENT OF EFFICACYAND GONADAL AND CARDIAC TOXICITY, Blood, 84(10), 1994, pp. 10000162-10000162